Microwave ablation therapy for treating primary and secondary lung tumours: technical note
Microwave ablation therapy for treating primary and secondary lung tumours: technical note
复制标题
DOI：
10.1007/s11547-010-0547-7
复制
发表时间：
2010-09-01
影响因子：
8.9
通讯作者：
Fugazzola, C.
中科院分区：
文献类型：
--
作者：
Carrafiello, G.;Mangini, M.;Fugazzola, C.
目的。本研究的目的是回顾性评价微波消融（MWA）治疗9例不可切除肺肿瘤的可行性、安全性和有效性。材料和方法。9例患者10次消融治疗10个病灶。使用45 W和915 MHz的微波发生器连接14.5号天线进行10分钟的治疗。天线放置在计算机断层扫描（CT）透视引导或XperGuide下进行。所有患者术后1、3、6个月均行CT随访。所有案例均取得了技术上的成功；30天死亡率为0%。本研究表明，在选定的患者中，MWA是其他消融技术的有效替代方法。需要进一步的研究来证明这种技术的短期和长期效果，并与其他可用的烧蚀系统进行比较，特别是与射频烧蚀系统进行比较。
Purpose. The purpose of our study was to retrospectively evaluate the feasibility, safety and effectiveness of microwave ablation (MWA) in nine patients with unresectable lung tumour.Materials and methods. Ten lesions were treated in ten ablation sessions in nine patients. The treatments were performed with a microwave generator with 45 W and 915 MHz connected to a 14.5-gauge antenna for 10 min. Antenna placement was performed with computed tomography (CT) fluoroscopy guidance or XperGuide. All patients underwent CT follow-up at 1, 3 and 6 months from the procedure.Results. Technical success was obtained in all cases; mortality at 30 days was 0%.Conclusions. This study shows that in selected patients, MWA is a valid alternative to other ablative techniques. Further studies are required to demonstrate the short- and long-term effects of this technique and to make a comparison with other available ablation systems, especially with radiofrequency.